STATUS OF ORPHAN DRUGS AND REIMBURSEMENT RECOMMENDATIONS AND DECISIONS IN ANALYSED EUROPEAN COUNTRIES

被引：0
|
作者：
Kawalec, P. [1 ]
Malinowski, K. [1 ]
机构：
[1] Jagiellonian Univ, Coll Med, Krakow, Poland
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1450
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY133
引用
下载
收藏
页码：A598 / A599
页数：2
相关论文
共 50 条
  • [1] Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries
    Stawowczyk, Ewa
    Malinowski, Krzysztof Piotr
    Kawalec, Pawel
    Bobinski, Rafal
    Siwiec, Jacek
    Panteli, Dimitra
    Eckhardt, Helene
    Simoens, Steven
    Agusti, Antonia
    Dooms, Marc
    Pilc, Andrzej
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [2] RECOMMENDATIONS AND REIMBURSEMENT STATUS OF ORPHAN DRUGS IN UE COUNTRIES
    Kawalec, P.
    VALUE IN HEALTH, 2015, 18 (07) : A678 - A678
  • [3] FACTORS PREDICTING REIMBURSEMENT DECISIONS ON ORPHAN DRUGS IN EIGHT COUNTRIES
    Kanters, T.
    Redekop, W.
    Hakkaart, L.
    VALUE IN HEALTH, 2012, 15 (07) : A308 - A308
  • [4] Societal preferences for granting orphan drugs special status in reimbursement decisions
    Reckers-Droog, Vivian
    Goossens, Lucas
    van Exel, Job
    Brouwer, Werner
    HEALTH POLICY AND TECHNOLOGY, 2024, 13 (02)
  • [5] The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe
    Kawalec, Pawel
    Sagan, Anna
    Pilc, Andrzej
    ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
  • [6] The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe
    Paweł Kawalec
    Anna Sagan
    Andrzej Pilc
    Orphanet Journal of Rare Diseases, 11
  • [7] CURRENT STATUS OF REIMBURSEMENT DECISIONS FOR ORPHAN DRUGS OR CANCER DRUGS AND IMPLEMENTATION FOR ACCESS SCHEMES IN KOREA
    Kim, Y.
    Na, Y.
    Yim, E.
    Kim, J.
    You, M. Y.
    VALUE IN HEALTH, 2014, 17 (07) : A654 - A654
  • [8] Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries
    Malinowski, Krzysztof Piotr
    Kawalec, Pawel
    Trabka, Wojciech
    Czech, Marcin
    Petrova, Guenka
    Manova, Manoela
    Savova, Alexandra
    Draganic, Pero
    Vostalova, Lenka
    Slaby, Juraj
    Mannikg, Agnes
    Marky, Kristof
    Rugaja, Zinta
    Gulbinovic, Jolanta
    Tesar, Tomas
    Paveliu, Marian Sorin
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [9] Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries
    Jakubowski, Szczepan
    Kawalec, Pawel
    Holko, Przemyslaw
    Kowalska-Bobko, Iwona
    Kamusheva, Maria
    Petrova, Guenka
    Draganic, Pero
    Fuksa, Leos
    Mannik, Agnes
    Ispan, Fanni
    Briedis, Vitalis
    Bianchi, Ioana
    Paveliu, Marian Sorin
    Tesar, Tomas
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [10] THE PATIENT PERSPECTIVE IN HEALTH TECHNOLOGY ASSESSMENT REIMBURSEMENT DECISIONS FOR ORPHAN DRUGS ACROSS DIFFERENT COUNTRIES
    Nicholson, L.
    Langham, S.
    Adkins, E.
    VALUE IN HEALTH, 2019, 22 : S860 - S860
12345